Pfizer Inc -One Pager Profile (1).pptx
•Download as PPTX, PDF•
0 likes•99 views
Pfizer Inc. is a global pharmaceutical company incorporated in 1942 and headquartered in New York. It operates through two business segments and has generated $11.8 billion in revenue in Q2 2020. Notable brands include Prevnar 13, Xeljanz, Eliquis, and Viagra. Recent updates include positive early data from its COVID-19 mRNA vaccine candidate, FDA approval for Xeljanz to treat juvenile arthritis, and declaration of a dividend for shareholders.
Report
Share
Report
Share
Recommended
Bharat Biotech Fact sheet
Bharat Biotech is an Indian biotechnology company that specializes in developing and manufacturing vaccines and biotherapeutics focused on public health in developing nations. It supplies vaccines to the Indian government and over 65 other countries. Bharat Biotech has large manufacturing facilities in Hyderabad, India that meet stringent international standards. The company is a leader in innovation and research and development, with a focus on diseases prevalent in developing market populations.
Cultural Inclusion and Diversity to jeopardise.
Jeopardise the inclusion and diversity across cultures.
Embracing Cultural Diversity in the Workplace.pptx
An intellectual insight on workplace diversity and inclusiveness.
Report on Business Pfizer Inc.Executive Summa.docx
Report on Business: Pfizer Inc.
Executive Summary
Pfizer has a long history in the biopharmaceutical industry, and a lengthy list of mergers and acquisitions. It has vast experience in creating lasting partnerships in the research and development, manufacturing, distributing, and marketing of its products. Pfizer seeks to improve the health of people everywhere through education and by making medications more accessible, which translates into better health beyond just the people it would employ here. Although there are risks such as potential job loss and environmental factors, the benefits outweigh these risks, and therefore it is recommended to allow Pfizer to set up operations in this country.
Company Description
Pfizer Inc. began operations in 1849 and has become the largest company specializing in biopharmaceuticals.It has operations in over 150 countries, with its headquarters located in New York, New York, USA. Pfizer employs more than 91,500 people and earned nearly $59 billion in 2012 revenues (Mergent, 2013). Operating in the pharmaceutical industry, it carries out the research, development,production,and marketing of goodssuch as over-the-counter and prescription medicines, vaccines, and consumer healthcare products. Advil, Lyrica, Lipitor, Celebrex, Viagra, and Prevnar are just a few of the blockbuster name brands made at Pfizer (Pfizer Inc., 2013).It recently divided its operations into three units, Primary Care, Specialty Care & Oncology, and Emerging Markets & Established Products, dropping the Animal Health and the Nutrition units through sales to Zoetis and Nestlé respectively (Staton, 2013). The Emerging Markets unitenables Pfizer’s vaccines and other medicines to reach developing countries, while Established Products handle the drugsthat have or will soon lose patent protection, as well as medicines acquired through licensing(Pfizer, 2013). Although revenues have been decreasing asa direct result of patents expiring, net profit is again increasing(Mergent, 2013) and appears to be stable in 2013 (U.S. Securities and Exchange Commission, 2013). Recent Income Statements and Revenues for the top-ten biopharmaceutical products can be viewed in Appendix A. Pfizer recently merged with the only remaining division of Wyeth, in India (Reuters, 2013); the original merger occurred in 2009 and led to the 2010 announcement that eight plants would be shut down in an effort to remain competitive and to prevent price increases (TopNews, 2010).
Company’s International Strategy
Pfizer grew the business internationally through mergers, acquisitions, and partnerships, which led to it being the world’s leading biopharmaceutical company. It has 100% ownership of all its numerous subsidiaries andmaintains operations in countries where it has acquired established companies that can continue to contribute to the growth of the business(Mergent, 2013). Its international strategy is closest to a transnational strategy due to the high costs of rese ...
Business Report on Pfizer
This document provides a business report on Pfizer Inc. prepared by Aileen Marshall. It includes an executive summary analyzing Pfizer's position in the pharmaceutical market. It then gives a company snapshot of Pfizer, including key facts, products, acquisitions and financial performance. Finally, it begins an analysis of Pfizer's current position using a PEST analysis and SWOT analysis to examine political, economic, social, technical, strengths, weaknesses, opportunities and threats facing the company.
Pfizer company analysis
This document summarizes Pfizer's history and global operations. It traces the company's founding in 1849 and key developments, including mass producing citric acid in 1900, producing penicillin in the 1940s, and launching Viagra in 1998. It provides financial data and notes Pfizer's global sales distribution, international growth through foreign expansion and acquisitions. The document also describes Pfizer's global strategy of replacing expiring patents through R&D, intellectual property protection, and financial strategies to coordinate its worldwide pharmaceutical manufacturing, marketing and distribution networks.
Pharmaceutical Industry Financial Analysis
This is a presentation that was completed for my Corporate Finance class my senior year with a team of three other students. I did my valuation of Eli Lilly.
The Pharma Partners - Introduction
The document provides advice and strategies for transformational growth in the pharmaceutical industry. It discusses how the traditional models of blockbuster drugs and generic copies are being disrupted, requiring companies to reinvent themselves. The key strategies suggested include focusing on niche specialty products, branded generics, consumer healthcare, emerging markets, and biotech/diagnostics. The document emphasizes the need to start transforming now through small steps and immediate opportunities. It introduces the advisory team at The Pharma Partners who have deep experience across various areas to help guide strategic transformations.
Recommended
Bharat Biotech Fact sheet
Bharat Biotech is an Indian biotechnology company that specializes in developing and manufacturing vaccines and biotherapeutics focused on public health in developing nations. It supplies vaccines to the Indian government and over 65 other countries. Bharat Biotech has large manufacturing facilities in Hyderabad, India that meet stringent international standards. The company is a leader in innovation and research and development, with a focus on diseases prevalent in developing market populations.
Cultural Inclusion and Diversity to jeopardise.
Jeopardise the inclusion and diversity across cultures.
Embracing Cultural Diversity in the Workplace.pptx
An intellectual insight on workplace diversity and inclusiveness.
Report on Business Pfizer Inc.Executive Summa.docx
Report on Business: Pfizer Inc.
Executive Summary
Pfizer has a long history in the biopharmaceutical industry, and a lengthy list of mergers and acquisitions. It has vast experience in creating lasting partnerships in the research and development, manufacturing, distributing, and marketing of its products. Pfizer seeks to improve the health of people everywhere through education and by making medications more accessible, which translates into better health beyond just the people it would employ here. Although there are risks such as potential job loss and environmental factors, the benefits outweigh these risks, and therefore it is recommended to allow Pfizer to set up operations in this country.
Company Description
Pfizer Inc. began operations in 1849 and has become the largest company specializing in biopharmaceuticals.It has operations in over 150 countries, with its headquarters located in New York, New York, USA. Pfizer employs more than 91,500 people and earned nearly $59 billion in 2012 revenues (Mergent, 2013). Operating in the pharmaceutical industry, it carries out the research, development,production,and marketing of goodssuch as over-the-counter and prescription medicines, vaccines, and consumer healthcare products. Advil, Lyrica, Lipitor, Celebrex, Viagra, and Prevnar are just a few of the blockbuster name brands made at Pfizer (Pfizer Inc., 2013).It recently divided its operations into three units, Primary Care, Specialty Care & Oncology, and Emerging Markets & Established Products, dropping the Animal Health and the Nutrition units through sales to Zoetis and Nestlé respectively (Staton, 2013). The Emerging Markets unitenables Pfizer’s vaccines and other medicines to reach developing countries, while Established Products handle the drugsthat have or will soon lose patent protection, as well as medicines acquired through licensing(Pfizer, 2013). Although revenues have been decreasing asa direct result of patents expiring, net profit is again increasing(Mergent, 2013) and appears to be stable in 2013 (U.S. Securities and Exchange Commission, 2013). Recent Income Statements and Revenues for the top-ten biopharmaceutical products can be viewed in Appendix A. Pfizer recently merged with the only remaining division of Wyeth, in India (Reuters, 2013); the original merger occurred in 2009 and led to the 2010 announcement that eight plants would be shut down in an effort to remain competitive and to prevent price increases (TopNews, 2010).
Company’s International Strategy
Pfizer grew the business internationally through mergers, acquisitions, and partnerships, which led to it being the world’s leading biopharmaceutical company. It has 100% ownership of all its numerous subsidiaries andmaintains operations in countries where it has acquired established companies that can continue to contribute to the growth of the business(Mergent, 2013). Its international strategy is closest to a transnational strategy due to the high costs of rese ...
Business Report on Pfizer
This document provides a business report on Pfizer Inc. prepared by Aileen Marshall. It includes an executive summary analyzing Pfizer's position in the pharmaceutical market. It then gives a company snapshot of Pfizer, including key facts, products, acquisitions and financial performance. Finally, it begins an analysis of Pfizer's current position using a PEST analysis and SWOT analysis to examine political, economic, social, technical, strengths, weaknesses, opportunities and threats facing the company.
Pfizer company analysis
This document summarizes Pfizer's history and global operations. It traces the company's founding in 1849 and key developments, including mass producing citric acid in 1900, producing penicillin in the 1940s, and launching Viagra in 1998. It provides financial data and notes Pfizer's global sales distribution, international growth through foreign expansion and acquisitions. The document also describes Pfizer's global strategy of replacing expiring patents through R&D, intellectual property protection, and financial strategies to coordinate its worldwide pharmaceutical manufacturing, marketing and distribution networks.
Pharmaceutical Industry Financial Analysis
This is a presentation that was completed for my Corporate Finance class my senior year with a team of three other students. I did my valuation of Eli Lilly.
The Pharma Partners - Introduction
The document provides advice and strategies for transformational growth in the pharmaceutical industry. It discusses how the traditional models of blockbuster drugs and generic copies are being disrupted, requiring companies to reinvent themselves. The key strategies suggested include focusing on niche specialty products, branded generics, consumer healthcare, emerging markets, and biotech/diagnostics. The document emphasizes the need to start transforming now through small steps and immediate opportunities. It introduces the advisory team at The Pharma Partners who have deep experience across various areas to help guide strategic transformations.
Dyadic fact sheet august 2018
Dyadic International is a global biotechnology company focused on improving and applying its proprietary C1 gene expression platform, a patented genetically modified strain of the fungus Myceliophthora thermophila, to address opportunities in human and animal health markets. The C1 platform can help bring biologic drugs to market faster, in greater volumes, and at lower cost than existing platforms like CHO cells. Dyadic pursues R&D collaborations and licensing arrangements to develop and manufacture biopharmaceuticals using the C1 platform.
Biotechnology 1
The document provides an overview of the pharmaceutical and biotechnology industries. It discusses how pharmaceutical companies produce drugs and other products, and how biotechnology companies use genetic research to develop products. It outlines trends in industry consolidation and partnerships between large pharmaceutical companies and smaller biotech firms. It also describes various career opportunities and paths within these industries.
5 different Entrepreneurship company
Bharat Biotech is an Indian biotechnology company founded in 1996 by Dr. Krishna Ella and headquartered in Hyderabad, India. It has developed several innovative vaccines through world-class research and owns over 160 global patents. Recently, it partnered with ICMR to develop India's first indigenous COVID-19 vaccine called Covaxin. The company aims to solve health challenges in developing countries by developing affordable vaccines and therapeutics.
Analyst Report
Pfizer is a large pharmaceutical company headquartered in New York. The company focuses on research and development in key therapeutic areas like immunology, oncology, and vaccines. Pfizer has seen increasing stock prices and profits over the past 5 years. The analyst recommends buying Pfizer stock as the company has a promising drug pipeline that could produce revolutionary new drugs and cause the stock price to rise substantially.
Nutrify today september 2021 bulletin
Nutrify Today has been working to add value to the responsible nutrition industry to the best of its capacity. In our pursuit of enabling and empowering responsible nutrition businesses; we are happy to bring to you a monthly bulletin on interesting business subjects in responsible nutrition. It will focus on new innovations, new patents, interesting business ideas, and opinions from industry stakeholders globally. We expect this bulletin to be a lead generator, business opportunities generator and potentially triggering of ideas that could lead to great responsible nutrition products. Feel free to contribute, suggest, advise at hello@nutrifytoday.com
Pfizer_Market_overview .pptx
This project comprises market overview of one of the leading pharmaceutical manufacturing company Pfizer. It consists company's historical background, Market status, Major critics faced by them. which is helpful for MBA & Marketing students and for further share holders looking up for companies outline. Prepared and submitted on October 2021
Genetic Technologies Biotech Showcase Presentation - December
Genetic Technologies Limited is a diversified molecular diagnostics company
developing tools for the prediction and assessment of cancer risk to help physicians
proactively manage patient health. The Company’s lead products, ‘GeneType for
Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk
assessment tests that are first in their class. The Company’s development pipeline
includes new tests for Type 2 diabetes, cardiovascular disease, prostate cancer, and
melanoma. Listed on the ASX in 2000 and NASDAQ in 2005, Genetic Technologies
has been a leader in the development and commercialization of genetic risk
assessment technology for 20 years.
Arm q2 2015_web%20version_final
The Alliance for Regenerative Medicine (ARM) is the leading global advocate for regenerative and advanced therapies. It fosters research, development, investment, and commercialization of transformative treatments and cures. ARM leverages the expertise of its members to promote legislative, regulatory, and public support for this expanding field of medicine.
Bio 2010 Burrill White Paper
The document discusses how biotech companies are responding to dramatic changes by forming strategic alliances. It provides examples of partnerships between small biotech companies and larger pharmaceutical companies. The partnerships allow biotechs to access capital to advance drug development programs in the difficult economic environment. The article suggests partnering will continue to be important for biotechs given the challenges of raising funds through other means such as IPOs.
The Business Of Science
This document provides an overview of the business model for therapeutic product discovery and development companies. It discusses key aspects like securing intellectual property and identifying a niche market. It also examines case studies of MedImmune and Panacea, highlighting strengths like management teams and weaknesses such as inefficient leadership. The document notes the high costs and risks involved but also the potential rewards, making it an attractive field for investors.
Ranvver sharma ppt
Ranveer Sharma from the Department of Biotech at Bcet Gurdaspur presented on Panacea Biotec. Panacea Biotec is an Indian healthcare company focused on pharmaceuticals, biopharmaceuticals, vaccines and natural products. It has a global footprint in over 30 countries. Key highlights included its #4 ranking in vaccines in India, state-of-the-art manufacturing facilities approved by US FDA and WHO, and strategic collaborations with companies like Serum Institute of India and Apotex. Recent updates discussed a collaboration with Serum Institute on a hexavalent vaccine and a settlement agreement with Celgene regarding patents on Panacea's generic version of Abraxane.
Kybora EM_ABI 2016
The document discusses trends in life science investing globally. It notes that while US and European healthcare IPO issuance and market volatility has fluctuated between 2010-2016, overall investment in healthcare IPOs and M&A transactions has generally increased. The document then outlines trends showing increased investment in biotech and life sciences globally, including rising investments in China and more venture capital going to biopharma companies in their Series A rounds. It concludes that given increasing medical spending, longer life expectancies and rapid innovation, it is a good time to start new life sciences businesses.
Lance Gordon CV 03042015
This curriculum vitae summarizes the career of Dr. Lance K. Gordon, including his extensive experience in vaccine development and leadership of biotechnology companies. He has held roles such as Director of Neglected Infectious Diseases at the Bill & Melinda Gates Foundation, President and CEO of multiple vaccine companies, and clinical roles earlier in his career. Dr. Gordon has overseen numerous vaccine development programs and clinical trials, with a focus on infectious diseases affecting developing countries.
BioPharm Insight financing in EU panel 2015
This document provides an overview of a panel discussion on innovative financing trends for European biotechs. The panel will discuss whether EU investors will increase their appetite for risk capital, alternative fundraising options for European companies to achieve more reasonable valuations, and if European companies should seek investment from US markets instead. While European biotech research is strong, US capital markets continue to offer European companies higher valuations, larger investments, and more liquidity compared to domestic exchanges. The panel aims to explore solutions to these regional challenges facing European drug innovators.
Pfizer
Pfizer is a large pharmaceutical company founded in 1849 and headquartered in New York. It has annual sales of $44.4 billion and focuses on areas like cardiovascular, infectious diseases, and oncology. While Pfizer has significant market share and resources, it also faces threats such as expiring patents, increased competition from generics, and a reliance on blockbuster drugs.
A study on sales and promotion startegies towards Excellent Biotechnologies
Excellent Biotechnologies is a leading biotech company in India that produces enzymes and chemicals. It aims to double its revenues to $50 million by 2020 by focusing on sales and promotion strategies. The biotech industry in India has experienced high growth of over 20% annually due to increasing investments, outsourcing, and government support. The future looks promising for the biotech sector to become a $100 billion industry by 2025.
Most emerging biotech companies to watch.pdf
1) Evozyne uses evolution-based design and machine learning to engineer novel proteins to solve challenges in therapeutics and sustainability.
2) They have partnered with Takeda to develop an enzyme to treat a genetic disease, exceeding expectations, and are developing platforms for antibodies, gene editing, and gene optimization.
3) Evozyne aims to bring biology-based solutions to issues like carbon capture and untreated diseases by designing proteins with advanced functionality inspired by natural evolution.
10 most innovative companies in the neutraceutical market
In our latest edition of Insights Care - 10 Most Innovative Companies in Nutraceutical Market, we shortlisted some reliable ones.
Riordan (Gilead Sciences) Schmergel (Genetics Institute) Vincent (Biogen) Bio...
Michael L Riordan, the founder & CEO of Gilead, Gabriel Schmergel, the CEO of Genetics Institute, and James L Vincent, the CEO of Biogen, are interviewed by G Steven Burrill regarding the state of the Biotech industry. 1991.
Christopher Anderson SPHR CBS VP HR Why is hr
Why is HR in the Biotech Industry different ?
Biotechnology is one of the most research intensive industries in the world. The first biotechnology product earning FDA approval was for synthetic “human” insulin in 1982 and was developed by Genentech and Eli Lilly.
Sunscreens, IP-I, Dr. M.N.CHISHTI, Asst Prof. Dept of Pharmaceutics, YBCCPA
Industrial Pharmacy -I, PCI syllabus
Test bank clinical nursing skills a concept based approach 4e pearson educati...
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson educationMore Related Content
Similar to Pfizer Inc -One Pager Profile (1).pptx
Dyadic fact sheet august 2018
Dyadic International is a global biotechnology company focused on improving and applying its proprietary C1 gene expression platform, a patented genetically modified strain of the fungus Myceliophthora thermophila, to address opportunities in human and animal health markets. The C1 platform can help bring biologic drugs to market faster, in greater volumes, and at lower cost than existing platforms like CHO cells. Dyadic pursues R&D collaborations and licensing arrangements to develop and manufacture biopharmaceuticals using the C1 platform.
Biotechnology 1
The document provides an overview of the pharmaceutical and biotechnology industries. It discusses how pharmaceutical companies produce drugs and other products, and how biotechnology companies use genetic research to develop products. It outlines trends in industry consolidation and partnerships between large pharmaceutical companies and smaller biotech firms. It also describes various career opportunities and paths within these industries.
5 different Entrepreneurship company
Bharat Biotech is an Indian biotechnology company founded in 1996 by Dr. Krishna Ella and headquartered in Hyderabad, India. It has developed several innovative vaccines through world-class research and owns over 160 global patents. Recently, it partnered with ICMR to develop India's first indigenous COVID-19 vaccine called Covaxin. The company aims to solve health challenges in developing countries by developing affordable vaccines and therapeutics.
Analyst Report
Pfizer is a large pharmaceutical company headquartered in New York. The company focuses on research and development in key therapeutic areas like immunology, oncology, and vaccines. Pfizer has seen increasing stock prices and profits over the past 5 years. The analyst recommends buying Pfizer stock as the company has a promising drug pipeline that could produce revolutionary new drugs and cause the stock price to rise substantially.
Nutrify today september 2021 bulletin
Nutrify Today has been working to add value to the responsible nutrition industry to the best of its capacity. In our pursuit of enabling and empowering responsible nutrition businesses; we are happy to bring to you a monthly bulletin on interesting business subjects in responsible nutrition. It will focus on new innovations, new patents, interesting business ideas, and opinions from industry stakeholders globally. We expect this bulletin to be a lead generator, business opportunities generator and potentially triggering of ideas that could lead to great responsible nutrition products. Feel free to contribute, suggest, advise at hello@nutrifytoday.com
Pfizer_Market_overview .pptx
This project comprises market overview of one of the leading pharmaceutical manufacturing company Pfizer. It consists company's historical background, Market status, Major critics faced by them. which is helpful for MBA & Marketing students and for further share holders looking up for companies outline. Prepared and submitted on October 2021
Genetic Technologies Biotech Showcase Presentation - December
Genetic Technologies Limited is a diversified molecular diagnostics company
developing tools for the prediction and assessment of cancer risk to help physicians
proactively manage patient health. The Company’s lead products, ‘GeneType for
Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk
assessment tests that are first in their class. The Company’s development pipeline
includes new tests for Type 2 diabetes, cardiovascular disease, prostate cancer, and
melanoma. Listed on the ASX in 2000 and NASDAQ in 2005, Genetic Technologies
has been a leader in the development and commercialization of genetic risk
assessment technology for 20 years.
Arm q2 2015_web%20version_final
The Alliance for Regenerative Medicine (ARM) is the leading global advocate for regenerative and advanced therapies. It fosters research, development, investment, and commercialization of transformative treatments and cures. ARM leverages the expertise of its members to promote legislative, regulatory, and public support for this expanding field of medicine.
Bio 2010 Burrill White Paper
The document discusses how biotech companies are responding to dramatic changes by forming strategic alliances. It provides examples of partnerships between small biotech companies and larger pharmaceutical companies. The partnerships allow biotechs to access capital to advance drug development programs in the difficult economic environment. The article suggests partnering will continue to be important for biotechs given the challenges of raising funds through other means such as IPOs.
The Business Of Science
This document provides an overview of the business model for therapeutic product discovery and development companies. It discusses key aspects like securing intellectual property and identifying a niche market. It also examines case studies of MedImmune and Panacea, highlighting strengths like management teams and weaknesses such as inefficient leadership. The document notes the high costs and risks involved but also the potential rewards, making it an attractive field for investors.
Ranvver sharma ppt
Ranveer Sharma from the Department of Biotech at Bcet Gurdaspur presented on Panacea Biotec. Panacea Biotec is an Indian healthcare company focused on pharmaceuticals, biopharmaceuticals, vaccines and natural products. It has a global footprint in over 30 countries. Key highlights included its #4 ranking in vaccines in India, state-of-the-art manufacturing facilities approved by US FDA and WHO, and strategic collaborations with companies like Serum Institute of India and Apotex. Recent updates discussed a collaboration with Serum Institute on a hexavalent vaccine and a settlement agreement with Celgene regarding patents on Panacea's generic version of Abraxane.
Kybora EM_ABI 2016
The document discusses trends in life science investing globally. It notes that while US and European healthcare IPO issuance and market volatility has fluctuated between 2010-2016, overall investment in healthcare IPOs and M&A transactions has generally increased. The document then outlines trends showing increased investment in biotech and life sciences globally, including rising investments in China and more venture capital going to biopharma companies in their Series A rounds. It concludes that given increasing medical spending, longer life expectancies and rapid innovation, it is a good time to start new life sciences businesses.
Lance Gordon CV 03042015
This curriculum vitae summarizes the career of Dr. Lance K. Gordon, including his extensive experience in vaccine development and leadership of biotechnology companies. He has held roles such as Director of Neglected Infectious Diseases at the Bill & Melinda Gates Foundation, President and CEO of multiple vaccine companies, and clinical roles earlier in his career. Dr. Gordon has overseen numerous vaccine development programs and clinical trials, with a focus on infectious diseases affecting developing countries.
BioPharm Insight financing in EU panel 2015
This document provides an overview of a panel discussion on innovative financing trends for European biotechs. The panel will discuss whether EU investors will increase their appetite for risk capital, alternative fundraising options for European companies to achieve more reasonable valuations, and if European companies should seek investment from US markets instead. While European biotech research is strong, US capital markets continue to offer European companies higher valuations, larger investments, and more liquidity compared to domestic exchanges. The panel aims to explore solutions to these regional challenges facing European drug innovators.
Pfizer
Pfizer is a large pharmaceutical company founded in 1849 and headquartered in New York. It has annual sales of $44.4 billion and focuses on areas like cardiovascular, infectious diseases, and oncology. While Pfizer has significant market share and resources, it also faces threats such as expiring patents, increased competition from generics, and a reliance on blockbuster drugs.
A study on sales and promotion startegies towards Excellent Biotechnologies
Excellent Biotechnologies is a leading biotech company in India that produces enzymes and chemicals. It aims to double its revenues to $50 million by 2020 by focusing on sales and promotion strategies. The biotech industry in India has experienced high growth of over 20% annually due to increasing investments, outsourcing, and government support. The future looks promising for the biotech sector to become a $100 billion industry by 2025.
Most emerging biotech companies to watch.pdf
1) Evozyne uses evolution-based design and machine learning to engineer novel proteins to solve challenges in therapeutics and sustainability.
2) They have partnered with Takeda to develop an enzyme to treat a genetic disease, exceeding expectations, and are developing platforms for antibodies, gene editing, and gene optimization.
3) Evozyne aims to bring biology-based solutions to issues like carbon capture and untreated diseases by designing proteins with advanced functionality inspired by natural evolution.
10 most innovative companies in the neutraceutical market
In our latest edition of Insights Care - 10 Most Innovative Companies in Nutraceutical Market, we shortlisted some reliable ones.
Riordan (Gilead Sciences) Schmergel (Genetics Institute) Vincent (Biogen) Bio...
Michael L Riordan, the founder & CEO of Gilead, Gabriel Schmergel, the CEO of Genetics Institute, and James L Vincent, the CEO of Biogen, are interviewed by G Steven Burrill regarding the state of the Biotech industry. 1991.
Christopher Anderson SPHR CBS VP HR Why is hr
Why is HR in the Biotech Industry different ?
Biotechnology is one of the most research intensive industries in the world. The first biotechnology product earning FDA approval was for synthetic “human” insulin in 1982 and was developed by Genentech and Eli Lilly.
Similar to Pfizer Inc -One Pager Profile (1).pptx (20)
Genetic Technologies Biotech Showcase Presentation - December
Genetic Technologies Biotech Showcase Presentation - December
A study on sales and promotion startegies towards Excellent Biotechnologies
A study on sales and promotion startegies towards Excellent Biotechnologies
10 most innovative companies in the neutraceutical market
10 most innovative companies in the neutraceutical market
Riordan (Gilead Sciences) Schmergel (Genetics Institute) Vincent (Biogen) Bio...
Riordan (Gilead Sciences) Schmergel (Genetics Institute) Vincent (Biogen) Bio...
Recently uploaded
Sunscreens, IP-I, Dr. M.N.CHISHTI, Asst Prof. Dept of Pharmaceutics, YBCCPA
Industrial Pharmacy -I, PCI syllabus
Test bank clinical nursing skills a concept based approach 4e pearson educati...
Test bank clinical nursing skills a concept based approach 4e pearson educati...rightmanforbloodline
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson education
Test bank clinical nursing skills a concept based approach 4e pearson educationTest bank calculating drug dosages a patient safe approach to nursing and mat...
Test bank calculating drug dosages a patient safe approach to nursing and mat...rightmanforbloodline
Test bank calculating drug dosages a patient safe approach to nursing and math 2nd edition by castillo werner mccullough
Test bank calculating drug dosages a patient safe approach to nursing and math 2nd edition by castillo werner mccullough
Test bank calculating drug dosages a patient safe approach to nursing and math 2nd edition by castillo werner mccullough𝔹hopal Call Girls 7023059433 High Profile Independent Escorts 𝔹hopal
𝔹hopal Call Girls 7023059433 High Profile Independent Escorts 𝔹hopal
Test bank advanced health assessment and differential diagnosis essentials fo...
Test bank advanced health assessment and differential diagnosis essentials fo...rightmanforbloodline
Test bank advanced health assessment and differential diagnosis essentials for clinical practice 1st edition myrick.
Test bank advanced health assessment and differential diagnosis essentials for clinical practice 1st edition myrick.
Test bank advanced health assessment and differential diagnosis essentials for clinical practice 1st edition myrick.GORDON'S 11 FUNCTIONAL PATTERN-Health Assessment.pptx
GORDON'S 11 FUNCTIONAL PATTERN-Health Assessment
Kolkata Call Girls 🔝 7374876321 🔝 Top Escorts Service Experiences With Fore...
Kolkata Call Girls 🔝 7374876321 🔝 Top Escorts Service Experiences With Foreignerj11
Call Girls Goa 7023059433 Celebrity Escorts Service in Goa
Call Girls Goa 7023059433 Celebrity Escorts Service in Goa
Hyderabad Call Girls 7023059433 High Profile Escorts Service Hyderabad
Hyderabad Call Girls 7023059433 High Profile Escorts Service Hyderabad
Discover the Perfect Way to Relax - Malayali Kerala Spa Ajman
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
Solution manual for managerial accounting 18th edition by ray garrison eric n...
Solution manual for managerial accounting 18th edition by ray garrison eric n...rightmanforbloodline
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressedExploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...
Exploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...Dr. David Greene Arizona
Dr. David Greene of Arizona is at the forefront of stem cell therapy for Parkinson's Disease, focusing on innovative treatments to restore dopamine-producing neurons. His research explores the use of embryonic stem cells, induced pluripotent stem cells, and adult stem cells to replace lost neurons and potentially reverse disease progression. By transplanting differentiated cells into affected brain areas, Dr. Greene aims to address the root cause of Parkinson's. His work also investigates the neuroprotective benefits of stem cells, offering hope for effective, long-term treatments. Discover how Dr. Greene's pioneering efforts could transform Parkinson's Disease therapy.Bashundhara Toiletries Logo Guideline 2024
It outlines the basic identity elements such as symbol, logotype, colors, and typefaces. It provides examples of applying the identity to materials like letterhead, business cards, reports, folders, and websites.
Luxury Massage Experience at Affordable Rate - Malayali Kerala Spa Ajman
At Malayali Kerala Spa Ajman we providing the top quality massage services for our customers.
Our massage center prioritizes efficiency to ensure a quality massage experience for our clients at Malayali Kerala Spa Ajman. We offer a convenient appointment system and precise massage services.
Reach us at Villa No 7, Near Ammar Bin Yasir Street Al Rashidiya 2 - Ajman - United Arab Emirates.
Phone : +971 529818279
EXAMINATION OF HUMAN URINE AND FAECES.pdf
This presentation will help to develop in-depth knowledge of the examination of Urine and Faeces.
The Ultimate Guide in Setting Up Market Research System in Health-Tech
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
Recently uploaded (20)
Sunscreens, IP-I, Dr. M.N.CHISHTI, Asst Prof. Dept of Pharmaceutics, YBCCPA
Sunscreens, IP-I, Dr. M.N.CHISHTI, Asst Prof. Dept of Pharmaceutics, YBCCPA
Test bank clinical nursing skills a concept based approach 4e pearson educati...
Test bank clinical nursing skills a concept based approach 4e pearson educati...
Test bank calculating drug dosages a patient safe approach to nursing and mat...
Test bank calculating drug dosages a patient safe approach to nursing and mat...
𝔹hopal Call Girls 7023059433 High Profile Independent Escorts 𝔹hopal
𝔹hopal Call Girls 7023059433 High Profile Independent Escorts 𝔹hopal
Test bank advanced health assessment and differential diagnosis essentials fo...
Test bank advanced health assessment and differential diagnosis essentials fo...
GORDON'S 11 FUNCTIONAL PATTERN-Health Assessment.pptx
GORDON'S 11 FUNCTIONAL PATTERN-Health Assessment.pptx
Kolkata Call Girls 🔝 7374876321 🔝 Top Escorts Service Experiences With Fore...
Kolkata Call Girls 🔝 7374876321 🔝 Top Escorts Service Experiences With Fore...
Call Girls Goa 7023059433 Celebrity Escorts Service in Goa
Call Girls Goa 7023059433 Celebrity Escorts Service in Goa
Hyderabad Call Girls 7023059433 High Profile Escorts Service Hyderabad
Hyderabad Call Girls 7023059433 High Profile Escorts Service Hyderabad
Discover the Perfect Way to Relax - Malayali Kerala Spa Ajman
Discover the Perfect Way to Relax - Malayali Kerala Spa Ajman
Footfalls & Heartbeats X Wearable X Breathing Survey (2).pdf
Footfalls & Heartbeats X Wearable X Breathing Survey (2).pdf
Solution manual for managerial accounting 18th edition by ray garrison eric n...
Solution manual for managerial accounting 18th edition by ray garrison eric n...
Exploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...
Exploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...
Luxury Massage Experience at Affordable Rate - Malayali Kerala Spa Ajman
Luxury Massage Experience at Affordable Rate - Malayali Kerala Spa Ajman
The Ultimate Guide in Setting Up Market Research System in Health-Tech
The Ultimate Guide in Setting Up Market Research System in Health-Tech
Pfizer Inc -One Pager Profile (1).pptx
- 1. Pfizer Inc. (NYSE: PFE) Company Overview Key Financials Recent Updates Management Bios Incorporated on June 2, 1942, Delaware, US, is a global pharmaceutical company. The company engaged in discovery, development and manufacture of healthcare products. The company operates through two business segments, Pfizer Innovative Health and Pfizer Essential Health. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra. It employs +88,300 employees worldwide and present in 125 countries globally. Pfizer has generated $11.8 Billion revenue in Q2 2020 and has 8 products with revenue greater than $1 Billion in 2019. The company has returned $16.9 billion to shareholders in FY 2019 through a combination of dividends and share repurchases. The company headquartered in New York, US. October 2020: The company has received fast track designation for Duchenne Muscular Dystrophy Investigational gene therapy. September 2020: U.S. FDA approves Pfizer’s Xeljanz for the treatment of active Polyarticular Course Juvenile Idiopathic Arthritis. September 2020: The company has declared 38 cent fourth quarter 2020 dividend on the company’s common stock. August 2020: Pfizer and BioNTech share positive early data on lead mRNA Vaccine candidate BNT162b2 against COVID-19. Albert Bourla (CEO): Mr. Bourla leads Pfizer for more than 25 years and holds senior position across range of markets. He holds a Ph.D. in the Biotechnology of Reproduction. Frank D Amelio (CFO, EVP): Prior Joining Pfizer, he was senior EVP of Alcatel Lucent. He was born and raised in New Jersey and earned his MBA in Finance from St. John’s University. Lidia Fonseca (CTO): Ms. Fonseca is responsible for developing and implementing an enterprise-wide digital strategy. Prior joining Pfizer she was a SVP & CIO at Quest Diagnostics. She has earned a bachelor’s degree from the University of California. 51.8 53.6 52.5 52.8 48.9 45.0 47.0 49.0 51.0 53.0 55.0 2019 2018 2017 2016 2015 Revenue (Bn)
Editor's Notes
- Sources: Company’s Filling / Website